GB0201273D0 - Fibronectin variants and screening methods - Google Patents

Fibronectin variants and screening methods

Info

Publication number
GB0201273D0
GB0201273D0 GBGB0201273.0A GB0201273A GB0201273D0 GB 0201273 D0 GB0201273 D0 GB 0201273D0 GB 0201273 A GB0201273 A GB 0201273A GB 0201273 D0 GB0201273 D0 GB 0201273D0
Authority
GB
United Kingdom
Prior art keywords
screening methods
fibronectin variants
fibronectin
variants
screening
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0201273.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB0201273.0A priority Critical patent/GB0201273D0/en
Publication of GB0201273D0 publication Critical patent/GB0201273D0/en
Priority to PCT/GB2003/000212 priority patent/WO2003062830A2/en
Priority to AU2003201688A priority patent/AU2003201688A1/en
Priority to US10/895,590 priority patent/US20050118661A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB0201273.0A 2002-01-21 2002-01-21 Fibronectin variants and screening methods Ceased GB0201273D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB0201273.0A GB0201273D0 (en) 2002-01-21 2002-01-21 Fibronectin variants and screening methods
PCT/GB2003/000212 WO2003062830A2 (en) 2002-01-21 2003-01-21 Fibronectin variants and screening methods
AU2003201688A AU2003201688A1 (en) 2002-01-21 2003-01-21 Fibronectin variants and screening methods
US10/895,590 US20050118661A1 (en) 2002-01-21 2004-07-21 Fibronectin variants and screening methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0201273.0A GB0201273D0 (en) 2002-01-21 2002-01-21 Fibronectin variants and screening methods

Publications (1)

Publication Number Publication Date
GB0201273D0 true GB0201273D0 (en) 2002-03-06

Family

ID=9929422

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0201273.0A Ceased GB0201273D0 (en) 2002-01-21 2002-01-21 Fibronectin variants and screening methods

Country Status (3)

Country Link
AU (1) AU2003201688A1 (en)
GB (1) GB0201273D0 (en)
WO (1) WO2003062830A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2670471A1 (en) * 2006-11-22 2008-06-05 Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
FR2976587B1 (en) * 2011-06-20 2015-04-03 Basf Beauty Care Solutions F IN VITRO DOSING METHOD BY IMMUNOLOGICAL TECHNIQUE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516421D0 (en) * 1985-06-28 1985-07-31 Biotechnology Interface Ltd Fibronectins
CA2075300A1 (en) * 1990-12-04 1992-06-05 Mount Sinai School Of Medicine Of The City University Of New York Therapeutic and diagnostic applications of fetal fibronectin

Also Published As

Publication number Publication date
WO2003062830A3 (en) 2004-03-04
WO2003062830A2 (en) 2003-07-31
AU2003201688A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
AU2003214977A8 (en) Glaucoma screening system and method
ZA200603882B (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides
IL175491A0 (en) Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides
EP1575495A4 (en) Compounds and methods
EP1582271A4 (en) Circular-cylinder sieve
EP1467916A4 (en) Container and methods associated therewith
AU2003268032A8 (en) Composition and methods for treatment and screening
EP1599904A4 (en) Lateral lubistor structure and method
GB0309397D0 (en) Screening methods
IL165112A0 (en) Variant integrinpolypeptides and thereof
GB0204387D0 (en) Screening process
EP1514930A4 (en) Novel screening method
PL1807599T3 (en) Screening arrangement and a method of mounting the screening arrangement
GB0320590D0 (en) Fixing means and methods
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
GB0201273D0 (en) Fibronectin variants and screening methods
EP1491207A4 (en) Novel screening method
AU2003286392A8 (en) 1microarrays and production thereof
GB0223984D0 (en) Methods for detecting teneurin signalling and related screening methods
AU2003303311A8 (en) Methods for selecting and screening for trasformants
HUP0501102A2 (en) Bone support arrangement and method
GB0205755D0 (en) Screening method
GB0206657D0 (en) Novel intermediate and process
GB0227876D0 (en) Process and supports
AU2003248955A8 (en) Screening method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)